284 related articles for article (PubMed ID: 15987233)
1. As-needed inhaled beta2-adrenoceptor agonists in moderate-to-severe asthma: current recommendations.
Cockcroft DW
Treat Respir Med; 2005; 4(3):169-74. PubMed ID: 15987233
[TBL] [Abstract][Full Text] [Related]
2. Clinical concerns with inhaled beta2-agonists: adult asthma.
Cockcroft DW
Clin Rev Allergy Immunol; 2006; 31(2-3):197-208. PubMed ID: 17085793
[TBL] [Abstract][Full Text] [Related]
3. Nocturnal asthma uncontrolled by inhaled corticosteroids: theophylline or long-acting beta2 agonists?
Holimon TD; Chafin CC; Self TH
Drugs; 2001; 61(3):391-418. PubMed ID: 11293649
[TBL] [Abstract][Full Text] [Related]
4. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults.
Ni CM; Greenstone IR; Ducharme FM
Cochrane Database Syst Rev; 2005 Apr; (2):CD005307. PubMed ID: 15846751
[TBL] [Abstract][Full Text] [Related]
5. Antagonism of long-acting beta2-adrenoceptor agonism.
Lipworth BJ
Br J Clin Pharmacol; 2002 Sep; 54(3):231-45. PubMed ID: 12236842
[TBL] [Abstract][Full Text] [Related]
6. Role of long-acting beta2-adrenergic agonists in asthma management based on updated asthma guidelines.
Prenner BM
Curr Opin Pulm Med; 2008 Jan; 14(1):57-63. PubMed ID: 18043276
[TBL] [Abstract][Full Text] [Related]
7. A benefit-risk assessment of inhaled long-acting beta2-agonists in the management of obstructive pulmonary disease.
Sovani MP; Whale CI; Tattersfield AE
Drug Saf; 2004; 27(10):689-715. PubMed ID: 15350154
[TBL] [Abstract][Full Text] [Related]
8. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM
Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410
[TBL] [Abstract][Full Text] [Related]
9. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.
Greenstone IR; Ni Chroinin MN; Masse V; Danish A; Magdalinos H; Zhang X; Ducharme FM
Cochrane Database Syst Rev; 2005 Oct; (4):CD005533. PubMed ID: 16235409
[TBL] [Abstract][Full Text] [Related]
10. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
Ram FS; Cates CJ; Ducharme FM
Cochrane Database Syst Rev; 2005 Jan; (1):CD003137. PubMed ID: 15674901
[TBL] [Abstract][Full Text] [Related]
11. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
Aziz I; Hall IP; McFarlane LC; Lipworth BJ
J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy of long-acting beta2-adrenoceptor agonists and corticosteroids for asthma.
Chung KF; Adcock IM
Treat Respir Med; 2004; 3(5):279-89. PubMed ID: 15606218
[TBL] [Abstract][Full Text] [Related]
13. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
Ducharme FM; Lasserson TJ; Cates CJ
Cochrane Database Syst Rev; 2006 Oct; (4):CD003137. PubMed ID: 17054161
[TBL] [Abstract][Full Text] [Related]
14. Treatment of childhood asthma: how do the available options compare?
Coghlan D; Powell C
Paediatr Drugs; 2003; 5(10):685-98. PubMed ID: 14510626
[TBL] [Abstract][Full Text] [Related]
15. Cost effectiveness of leukotriene receptor antagonists versus long-acting beta-2 agonists as add-on therapy to inhaled corticosteroids for asthma: a pragmatic trial.
Wilson EC; Price D; Musgrave SD; Sims EJ; Shepstone L; Murdoch J; Mugford HM; Blyth A; Juniper EF; Ayres JG; Wolfe S; Freeman D; Gilbert RF; Hillyer EV; Harvey I
Pharmacoeconomics; 2010; 28(7):597-608. PubMed ID: 20446755
[TBL] [Abstract][Full Text] [Related]
16. Asthma treatment: inhaled beta-agonists.
Sears MR
Can Respir J; 1998; 5 Suppl A():54A-9A. PubMed ID: 9753519
[TBL] [Abstract][Full Text] [Related]
17. Effects of on-demand beta2-agonist inhalation in moderate-to-severe asthma. A randomized controlled trial.
Richter B; Bender R; Berger M
J Intern Med; 2000 Jun; 247(6):657-66. PubMed ID: 10886487
[TBL] [Abstract][Full Text] [Related]
18. Rescue treatment in asthma. More than as-needed bronchodilation.
Papi A; Caramori G; Adcock IM; Barnes PJ
Chest; 2009 Jun; 135(6):1628-1633. PubMed ID: 19497897
[TBL] [Abstract][Full Text] [Related]
19. Adverse effects of beta-agonists: are they clinically relevant?
Abramson MJ; Walters J; Walters EH
Am J Respir Med; 2003; 2(4):287-97. PubMed ID: 14719995
[TBL] [Abstract][Full Text] [Related]
20. Regular inhaled salbutamol and asthma control: the TRUST randomised trial. Therapy Working Group of the National Asthma Task Force and the MRC General Practice Research Framework.
Dennis SM; Sharp SJ; Vickers MR; Frost CD; Crompton GK; Barnes PJ; Lee TH
Lancet; 2000 May; 355(9216):1675-9. PubMed ID: 10905242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
